Similar Articles
New molecule in Parkinson’s disease treatment: Safinamide (monoamine oxidase-B plus inhibitor)
Murat Gültekin, Beyzanur Altıkulaç Ilikhan
DOI: 10.5606/phhb.dergisi.2025.49
Issue: 2025, Volume 28 - Issue 2-3
0
1
A case of Parkinson’s disease with clinical deterioration specific to constipation periods
Funda Kaplan, Zehra Yavuz, Özlem Munis Bizpınar, Selim Selçuk Çomoğlu
DOI: 10.5606/phhb.dergisi.2025.33
Issue: 2025, Volume 28 - Issue 2-3
0
2
Beta-ureidopropionase deficiency as a rare cause of dystonia
Dilek İşcan, Zehra Yavuz, Selim Selçuk Çomoğlu
DOI: 10.5606/phhb.dergisi.2025.36
Issue: 2025, Volume 28 - Issue 2-3
0
2